MSCI (MSCI) has drawn fresh attention after reporting second quarter 2026 earnings, with sales of US$867 million and net income of US$342 million, along with higher basic and diluted earnings per share compared with a year earlier.

MSCI's recent earnings and capital return actions, including the quarterly dividend and ongoing share repurchases, come as the share price has slipped over the past week and quarter, while the 1 year total shareholder return of 2.23% and 3 year total shareholder return of 3.87% show only modest progress overall.

If MSCI's recent moves have you reassessing your portfolio, this could be a good moment to broaden your search and uncover opportunities in 18 top founder-led companies

Bulls will point to MSCI's rising revenue and earnings, while bears will highlight the recent share price drift and relatively modest multi year returns. Which side does the valuation point toward next?

Most Popular Narrative: 32.3% Overvalued

MSCI last closed at $550.79, while the most followed narrative, according to Esteban, places fair value at $416.40 using an 8.17% discount rate. This sets up a clear valuation gap for investors to weigh.

MSCI is a Wide Moat compounding machine whose index benchmarks serve as the institutional standard for $16.5 trillion in global AUM, generating 75%+ recurring revenue at 93-95% retention rates and approximately 50% FCF margins. The investment thesis rests on three durable pillars: (1) permanent switching costs in the Index segment, where fund mandate rewrites, LP notifications, and derivative contract renegotiations make benchmark migration prohibitively costly for all but the most determined sponsors; (2) secular tailwinds from the continued growth of passive investing and the institutionalization of private markets, which expand MSCI's AUM-linked revenue with zero incremental cost; and (3) an emerging private assets franchise replicating the Index playbook in a $10 trillion+ private equity and credit market that currently lacks institutional-grade benchmarks.

Curious how a business built on high retention, recurring revenue and rich margins still screens as overvalued in this narrative? The answer lies in the growth runway and the earnings multiple Esteban assumes for MSCI years from now, plus how those cash flows are discounted back to today.

Result: Fair Value of $416.40 (OVERVALUED)

However, if MSCI's subscription model weakens or passive investing slows, the high recurring revenue and margin assumptions in this narrative could quickly look too optimistic.

Another View: What MSCI's P/E Says About Value

Esteban's narrative suggests MSCI is 32.3% overvalued at $550.79 versus a fair value of $416.40. Yet on a P/E of 29.5x, MSCI trades slightly below peers at 30.9x and well below the US Capital Markets industry on 39.3x, while still sitting above a fair ratio of 17.2x.

That mix of a relative discount to peers and a premium to the fair ratio points to a trade-off. The stock could re-rate closer to peers or slip back toward the fair ratio if expectations reset. Which side of that tension feels more likely to you?

Next Steps

With mixed signals around MSCI's valuation and fundamentals, this is a moment to look at the details yourself and move with conviction. To see how the positives and negatives compare in one place, review the 5 key rewards and 1 important warning sign

Looking for more investment ideas beyond MSCI?

If MSCI has you thinking more carefully about valuation and quality, this is the time to widen your lens and spot opportunities that others might be missing.

• Target potential mispricings by scanning companies that combine quality and attractive prices through the 50 high quality undervalued stocks
• Prioritize resilience and sleep better at night by focusing on companies flagged in the 79 resilient stocks with low risk scores
• Hunt for under the radar opportunities with strong fundamentals using the screener containing 19 high quality undiscovered gems

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.